Legend Biotech Corporation header image

Legend Biotech Corporation

LEGN

Equity

ISIN null / Valor 54834759

NASDAQ (2026-09-28)
USD 18.62-2.56%

Legend Biotech Corporation
UMushroom community rating:

star star star star star
4.00 11 votes No rating yet
NegativeNeutralPositive

About company

Legend Biotech Corporation is a biotechnology company focused on developing investigational agents and innovative technologies in personalized medicine, with a particular emphasis on cell therapies for treating hematological malignancies and solid tumors. The company is dedicated to exploring the potential of cell therapies to address diseases that are considered intractable and incurable. Through its pipeline of cutting-edge therapies, Legend Biotech aims to provide new treatment options for patients with challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-44.2%1Y
-72.3%3Y
-60.1%5Y

Performance

70.2%1Y
55.8%3Y
56.1%5Y

Volatility

Market cap

3608 M

Market cap (USD)

Daily traded volume (Shares)

1,714,951

Daily traded volume (Shares)

1 day high/low

32.9 / 32.18

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

11 votes
Performance:
starstarstarstarstar
4.04
Innovation:
starstarstarstarstar
4.36
Society:
starstarstarstarstar
4.18
Nature:
starstarstarstarstar
4.14
Thomas Yarwood
UK, 09 Mar 2026
star star star star star
Growth potential
Thomas Yarwood
UK, 25 Feb 2026
star star star star star
Growth potential
ola ho
UK, 22 Feb 2026
star star star star star
n/a

EQUITIES OF THE SAME SECTOR

Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%CHF 53.62
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc Protagonist Therapeutics Inc Valor: 33278818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%USD 142.44
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 88.44
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.22%CHF 2.20
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 91.62
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%CHF 82.60
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%USD 319.18
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%CHF 44.08
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 373.56
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd Torrent Pharmaceuticals Ltd Valor: 2431611
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.32%INR 4,869.40